drugset / Trial / NCT04404400

Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency

NCT04404400

Phase 3 Recruiting 1092 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims at assessing the efficacy and the safety of hydrocortisone combined with fludrocortisone compared to placebo in ICU adults with critical illness related corticosteroid insufficiency.

Timeline

Start
2022-02-17
Primary completion
2026-02
Completion
2026-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fludrocortisone Other / unclassified 50 ug Other
Subject Hydrocortisone Other / unclassified 50 mg Intravenous